Isnt this odx23 Nov 2020 17:05
Under treatment
More results are expected for immunomodulatory drugs, anti-virals, antibiotics, therapeutic antibodies and convalescent plasma for patients in different stages of the illness and various care settings, including hospitals and intensive care, primary care and care home patients.
34. Antibodies are an important component in managing COVID-19 in everyday lives. They can be used therapeutically for infected patients and prophylactically for immunocompromised patients who cannot receive vaccines. The Government is
supporting efforts to research and produce effective antibody therapies and phase III trials are ongoing.